AIP.NASDAQArteris, INC

Form 4: Arteris Director Saiyed Atiq Raza Reports Acquisition of Restricted Stock Units

Sentiment:

Insider Transaction Report


Arteris, Inc. Director Saiyed Atiq Raza has reported the acquisition of 20,839 restricted stock units (RSUs) on June 3, 2025, as part of his compensation.

Summary

  • Saiyed Atiq Raza, a Director of Arteris, Inc. (AIP), reported the acquisition of securities on June 3, 2025.
  • The transaction involved the acquisition of 20,839 Restricted Stock Units (RSUs) of Arteris, Inc. common stock.
  • The RSUs were acquired at a price of $0.00 per unit, indicating a grant rather than a purchase.
  • These RSUs represent a contingent right to receive one share of the Issuer's common stock each.
  • The RSUs are scheduled to vest in full on the earlier of (i) the first anniversary of the grant date or (ii) immediately before the annual meeting of the Issuer's stockholders following the grant date, subject to continued service.
  • Following this transaction, Saiyed Atiq Raza directly beneficially owns 40,126 shares of common stock.
  • Additionally, he indirectly beneficially owns 684,320 shares of common stock through the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust, for which he serves as trustee.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a director is a positive sign of aligning management interests with shareholders, though it is a routine compensation event rather than a significant operational or financial announcement that would drastically alter the company's outlook.

Positives

  • The grant of 20,839 Restricted Stock Units (RSUs) to Director Saiyed Atiq Raza aligns his interests with those of shareholders, as the value of the RSUs is directly tied to the company's stock performance.
  • The acquisition of RSUs at a $0.00 price is a common form of equity compensation for directors, serving as an incentive for long-term commitment and performance.

Future Outlook

The acquired Restricted Stock Units (RSUs) are scheduled to vest in full on the earlier of the first anniversary of the grant date (June 3, 2026) or immediately before the annual meeting of the Issuer's stockholders following the grant date, contingent on the reporting person continuing to provide services to the Issuer's Board through such vesting date.

Industry Context

NA (This document is a specific insider transaction report and does not provide broader industry context or trends.)

Related Party Transactions

  • Indirect beneficial ownership of 684,320 shares is held by the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust, for which the reporting person serves as trustee, indicating a related party holding.

Stakeholder Impact

  • Shareholders: The grant of RSUs to a director aligns his financial interests with the long-term performance of the company's stock, potentially benefiting shareholders if the stock price increases due to improved company performance.

Next Steps

  • The 20,839 Restricted Stock Units (RSUs) are expected to vest on the earlier of June 3, 2026, or immediately before the Issuer's annual stockholders' meeting following the grant date, provided the director continues to serve.

Key Dates

DateDescription
06/03/2025Date of transaction: acquisition of 20,839 Restricted Stock Units (RSUs).
06/05/2025Date the Form 4 was signed by the attorney-in-fact for S. Atiq Raza.

Recommendation

hold

Keywords

Arteris Inc., AIP, SEC Form 4, Insider Trading, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Saiyed Atiq Raza

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.